Please ensure Javascript is enabled for purposes of website accessibility

Google Prescribes More Partners

By Brian Orelli, PhD – Updated Apr 5, 2017 at 8:59PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The online giant's health-information service snags another important ally.

It's only been a few months since Google (NYSE:GOOG) launched its new health-information aggregation service, but it's already racked up quite a few partners in an effort to overtake Microsoft (NASDAQ:MSFT), WebMD (NASDAQ:WBMD), and Revolution Health, which all predated Google's efforts with similar websites to store health-care information.

Making importing your medical data easy is the key to successfully getting people to use the service. Who the heck would want to have to type in every drug they've ever taken, or decipher their doctor's chicken scratch?

Google Health's founding partners -- CVS Caremark (NYSE:CVS), Walgreen (NYSE:WAG), mail-order benefit manager MedcoHealth Solutions (NYSE:MHS), and laboratory-testing company Quest Diagnostics (NYSE:DGX) just to name a few -- were all a good start, but the search giant has apparently gone up the food chain to sign up the mother of all pharmacy clients.

Instead of signing up each individual client, Google Health is partnering with PDX, a provider of client tracking software to almost 3,000 pharmacies. Now, 55 million customers could potentially integrate their pharmaceutical records into Google Health.

Since PDX is just the software maker, Google Health will still have to sign up the pharmacies individually, but the pitch shouldn't be nearly as hard, since PDX has done all the work to create seamless integration between the pharmacies' databases and Google Health.

Until Google Health establishes a way to get most doctors' records into its system, I think it'll probably remain a niche product, but the partnership with PDX definitely shows that Google has the right prescription for success.

More Foolishness Googled up for you:

Microsoft and Quest Diagnostics are Motley Fool Inside Value selections. Google is a Motley Fool Rule Breakers pick. MedcoHealth Solutions is a Motley Fool Stock Advisor recommendation. Try any of our Foolish newsletters today, free for 30 days

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$237.45 (-0.20%) $0.47
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$97.74 (-0.62%) $0.61
Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$32.69 (-0.43%) $0.14
Quest Diagnostics Incorporated Stock Quote
Quest Diagnostics Incorporated
DGX
$123.20 (0.69%) $0.85
WebMD Health Corp. Stock Quote
WebMD Health Corp.
WBMD
Medco Health Solutions, Inc. Stock Quote
Medco Health Solutions, Inc.
MHS.DL

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.